πŸ‡ΊπŸ‡Έ FDA
Patent

US 10626129

Heteroaryl inhibitors of PDE4

granted A61KA61K31/435A61K31/44

Quick answer

US patent 10626129 (Heteroaryl inhibitors of PDE4) held by Tetra Discovery Partners expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tetra Discovery Partners
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/435, A61K31/44, A61K31/4418, A61K31/496